# Atrium Therapeutics, Inc. (RNA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RNA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 22.64M | $ -36.82M | $ -37.20M | $ 1.68M | $ 214.58M |
| 2025 | $ 879.5K | $ -49.22M | $ -20.61M | $ 3.67M | $ 207.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.31 |
| Current Ratio | 8.73 |

## Other views

- [Metrics](https://sponda.capital/en/RNA.md)
- [Charts](https://sponda.capital/en/RNA/charts.md)
- [Compare](https://sponda.capital/en/RNA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.